• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$41.23 $0.05 (0.12%)

REAL-TIME: Last trade at

AstraZeneca plc (ADR)

NYSE:AZN

Jump to this page for:

Related Resources

AstraZeneca Buys Back 130,000 Own Shares To Cancel/2609P

5/28/2012 by Smart Money

Have J&J's Approval Hopes Vanished?

5/26/2012 by DailyFinance

AstraZeneca Buys Back 153,000 Shares/2605P

5/25/2012 by Smart Money

Pfizer: A $22 Stock Worth $25

5/25/2012 by Seeking Alpha

Best of the Blogs, Biotech: Is an Anti-Obesity Drug Finally in Sight?

5/24/2012 by Minyanville

AstraZeneca Buys Back 600,000 Shares

5/24/2012 by Smart Money

Healthcare Dogs Stay Steady In April

5/24/2012 by Seeking Alpha

Johnson & Johnson: An Uncommon Opportunity

5/24/2012 by Seeking Alpha

Top International Dividend Stocks - May 2012 - Danger Ahead!

5/23/2012 by Seeking Alpha

JNJ Updates: Positives For Xarelto & Simponi

5/23/2012 by Trefis

Chelsea: A Short-Term Buying Opportunity

5/23/2012 by Seeking Alpha

Are 3 Failed Phase 3 Trials Enough?

5/23/2012 by DailyFinance

JNJ Updates: Imodium Recalls; Heading For Chinese Acquisitions; Zytiga’s Success

5/23/2012 by Trefis

The FTSE's Cheapest Shares in the Storm

5/22/2012 by DailyFinance

Buffett and Woodford Agree on This One!

5/22/2012 by DailyFinance

Drugmakers Assessing Emergency Action For Greece If Needed

5/21/2012 by Smart Money

Drugmakers Assess Contingency Plan For Greece

5/21/2012 by Smart Money

AstraZeneca Buys 360,000 Own Shares To Cancel

5/18/2012 by Smart Money

Merck KGaA's Erbitux Faces Hurdle - Analyst Blog

5/17/2012 by Nasdaq

AstraZeneca Buys Back 500,000 Shares To Cancel/2632P

5/17/2012 by Smart Money

Why U.K. Bonds Are for Losers

5/17/2012 by DailyFinance

Myriad to Present Cancer Test Study - Analyst Blog

5/17/2012 by Nasdaq

AstraZeneca Buys 0.6 Million Own Shares To Cancel

5/16/2012 by Smart Money

2nd UPDATE: UK Lawmakers Say Parallel Trade Causing Drug Shortages

5/15/2012 by Smart Money

3rd UPDATE: UK Lawmakers Say Parallel Trade Causing Drug Shortages

5/15/2012 by Smart Money

AstraZeneca Buys Back 315,751 Shares/2691P

5/14/2012 by Smart Money

Avoid These 2 Plunging Biotechs

5/14/2012 by DailyFinance

AstraZeneca Buys Back 316,716 Shares At 2682P/Share

5/11/2012 by Smart Money

AstraZeneca Buys Back 316,391 Shares

5/10/2012 by Smart Money

A Much-Needed Win for Pfizer

5/10/2012 by DailyFinance

Loss Widens at Ardea, Awaits Takeover - Analyst Blog

5/9/2012 by Nasdaq

British Small Caps Ready to Take On the World

5/9/2012 by DailyFinance

Regeneron Dips on Safety Concern Over Gout Treatment [UPDATE]

5/9/2012 by Minyanville

UK Health Watchdog Backs Lung Cancer Drug From Roche

5/9/2012 by Smart Money

UPDATE: Knight Capital Group Loses Shareholder Vote On Pay

5/9/2012 by Smart Money

Par Pharma Beats on All Fronts - Analyst Blog

5/9/2012 by Nasdaq

3rd UPDATE: Aviva CEO Moss Quits As Investor Rebellion Gathers Pace

5/8/2012 by Smart Money

Angry Investors See Off Aviva CEO As Holders Wield New Power

5/8/2012 by Smart Money

Has InterMune Become the Perfect Stock?

5/7/2012 by DailyFinance

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

5/4/2012 by Smart Money
See More Articles...